Neopterin in acute pancreatitis

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 10, 1996, Pages 1032-1036

  Uomo, G ^a   Spada, O A ^b   Manes, G ^b   Feola, B ^b   Misso, S ^b   Cavallera, A ^b   Rabitti, P G ^b  

^a CARDARELLI HOSPITAL   (Italy)

^b NONE

Author keywords

acute pancreatitis; immune system; interleukin 6; neopterin; prognostic assessment; tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MACROPHAGE ACTIVATION; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0029820609     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609003125     Document Type: Article

References (28)

1. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988;3:105-12.
2. Gross V, Scholmerich J, Leser HG, Salm R, Lausen M, Ruchauer K, et al. Granulocyte elastase in assessment of seventy of acute pancreatitis. Comparison with acute-phase proteins, C-reactive protein, α1-antitripsyn and protease inhibitor α2 macroglobulin. Dig Dis Sci 1990;35:97-105.
3. Bergenfeldt M, Berling R, Ohlsson K. Levels of leukocyte proteases in plasma and peritoneal exudate in severe acute pancreatitis. Scand J Gastroenterol 1994;29:371-5.
4. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J. Endotoxaemia and serum tumor necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-8.
5. Heath DJ, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute-phase protein response and potential as an early means of severity in acute pancreatitis. Gut 1993;34:41-5.
6. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lansen M. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992;22:200-3.
7. Dominguez-Munoz JE, Carballo F, Garcia MJ, de Diego JM, Gea F, Yanguela J, et al. Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitis. Results of a prospective multicenter study. Dig Dis Sci 1993;38:507-13.
8. Wilson C, Haeds A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989;76:177-81.
9. Mueller MM, Curtius HC, Herold M, Hueber CH. Neopterin in clinical practice. Clin Chim Acta 1991;201:1-16.
10. Iwagaki H, Hizuta A, Tanaka N, Orita K. Plasma neopterin/C-reactive protein ratio as adjunct to the assessment of infection and cancer cachexia. Immunol Invest 1995;24:479-87.
11. Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis. Eur J Clin Chem Clin Biochem 1994;32:685-9.
12. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H. Neopterin and soluble tumor necrosis factor receptor type 1 in alcohol-induced cirrhosis. Hepatology 1995; 21:976-8.
13. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg. 1993;128:568-90.
14. Sanfey H, Bulkley GB, Cameron JL. The role of oxygen free radicals in the pathogenesis of acute pancreatitis. Ann Surg 1984;200:405-13.
15. Pezzilli R, Billi P, Beltrandi E, Maldini M, Mancini R, Morselli Labate AM, et al. Circulating lymphocyte subsets in human acute pancreatitis. Pancreas 1995;11:95-100.
16. Werner ER, Werner-Felmayer G, Fuchs D, Hausen G, Reibnegger G, Wachter H. Tetrahydrobiopterin biosinthetic activation in human macrophages, fibroblasts, THP-1 and T24 cells. J Biol Chem 1990;265:3189-92.
17. Taych MA, Marlette MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as cofactor. J Biol Chem 1989;264:19654-8.
18. Nathan C. Nitric oxide and biopterin: a study in chiaroscuro. J Clin Invest 1994;93:1875-6.
19. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
20. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. The relationship between pancreatic enzyme release and activation and acute-phase protein response in patients with acute pancreatitis. Pancreas 1995;10:347-53.
21. Evans SW, Bank RE, Alexander D, McMahon MJ, Wichter JT. Is fatal pancreatitis the consequence of excessive macrophage stimulation? Gut 1990;31:A487.
22. Heinisch A, Ballé C, Kadow R, Mann S, Mann U, Messmann H, et al. Endogenous anticytokines determine the prognosis of severe acute pancreatitis. Gastroenterology 1995;108:A359.
23. Ranson JHC, Pasternak BS. Etiology and prognostic factors in human acute pancreatitis. Am J Gastroenterol 1982;77:633-8.
24. Banks P. Prediction of severity in acute pancreatitis. Pancreas 1991;6 Suppl: 7-12.
25. Heath DI, Imrie CW. The diagnosis and assessment of severity in acute pancreatitis. In: Johnson CD, Imrie CW, editors. Pancreatic disease - progress and prospects. London: Springer-Verlag, 1991:263-85.
26. Talamini G, Bassi G, Falconi M, Sartori N, Frulloni L, Di Francesco V, et al. Risk of death from acute pancreatitis. Role of early, simple routine data, Int J Pancreatol 1996. In press.
27. Uomo G, Rabitti PG, Laccetti M, Carraturo I, Esposito P, Visconti M. Prognostic assessment of necrotizing acute pancreatitis: results of a prospective study. Presse Med 1995; 24:263-6.
28. deBeaux AC, Palmer KR, Carter DC. Factor influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995;37:121-6.